Drug Approval | July 26, 2024
Sun Pharmaceutical receives USFDA approval for oral JAK inhibitor ‘Leqselvi’
Leqselvi delivered statistically significant efficacy across two Phase 3 clinical trials
Leqselvi delivered statistically significant efficacy across two Phase 3 clinical trials
NexGard Spectra is a soft, flavourful monthly chew that kills fleas before they can lay eggs
Winlevi is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Developed by Pfizer, Abrocitinib has received marketing authorization from the Central Drugs Standard Control Organization (CDSCO) in India
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
Agreed Price of US$43 per share to deliver 48% premium to unaffected price on May 25, 2023
The deal includes upfront payments, milestone payments and ongoing royalties
General Medicine grows 5% and Vaccines 10% led by Shingrix
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
Subscribe To Our Newsletter & Stay Updated
